Clinicopathologic Analysis and Prognosis of Endodermal Sinus Tumor of the Ovary. |
Min Hyung Jung, Sun Jung Park, Dae Yeon Kim, Jong Hyeok Kim, Yong Man Kim, Young Tak Kim, Joo Hyun Nam, Jung Eun Mok |
Department of Obstetrics and Gynecology, College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea. ymkim@amc.seoul.kr |
|
Abstract |
OBJECTIVE To evaluate the clinical and pathological characteristics of endodermal sinus tumor (EST) of the ovary. METHODS: Seventeen patients who were treated with EST of the ovary between September 1991 and February 2005 were reviewed retrospectively for clinicopathologic characteristics, treatments, and outcomes. RESULTS: Median age at diagnosis was 22.0 years (range 7-43). Nine patients (52.9%) were stage I, 3 (17.6%) stage II, 4 (23.5%) stage III, and 1 (5.9%) stage IV. Twelve of 17 patients underwent conservative surgery including unilateral salpingo-oophorectomy, unilateral oophorectomy and others were underwent total abdominal hysterectomy with bilateral salpingo-oophorectomy. All patients received adjuvant combination chemotherapy. Eleven patients received BEP (bleomycin, etoposide, cisplatin) combination chemotherapy and the others received VAC (vincristine, actinomycin D, cyclophosphamide). One patient had recurred, and 3 patients had died of the disease. The mean overall survival is 153.6 months. Patients with stage I and II had a more favorable prognosis than those with stage III and IV disease (p<0.05). Patients received BEP combination chemotherapy showed significantly better prognosis than patients received VAC (p<0.05). CONCLUSION: Less advanced stage and BEP combination chemotherapy showed significantly better prognosis. |
Key Words:
Ovary, Endodermal sinus tumor, Prognostic factors |
|